Dong-A Pharmaceutical, merged, posts ₩431.0B 3Q revenue… affiliates also cheerful
Predicted impact: Low
Q3 revenue of ₩431B and profit up 5%; modest relative to company size.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.